Merck & Co. Deferred Taxes increased by 3.8% to $1.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $1.41B to $1.49B. Over 5 years (FY 2020 to FY 2025), Deferred Taxes shows an upward trend with a 7.4% CAGR.
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
other_deferred_income_tax_liabilities_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.49B | $1.53B | $3.44B | $3.07B | $2.97B | $2.42B | $1.80B | $1.44B | $996.00M | $1.02B | $871.00M | $922.00M | $876.00M | $864.00M | $1.39B | $1.41B | $1.43B | $1.38B | $1.44B | $1.49B |
| QoQ Change | — | +2.6% | +125.3% | -10.8% | -3.2% | -18.7% | -25.7% | -19.7% | -30.9% | +2.2% | -14.4% | +5.9% | -5.0% | -1.4% | +60.5% | +1.6% | +1.3% | -3.2% | +4.2% | +3.8% |
| YoY Change | — | — | — | — | +99.7% | +58.3% | -47.8% | -53.0% | -66.5% | -57.9% | -51.5% | -36.1% | -12.0% | -15.1% | +59.2% | +52.8% | +62.9% | +59.8% | +3.7% | +6.0% |